Newsfeeds - Spark Newswire

4 minute read

The Week Ahead In Biotech (Nov. 14-Nov. 20): BioMarin FDA Decision, Tapering Earnings News Flow, Conference Presentations And More

Today, 1:39 PM

Biotech stocks declined for the second straight week amid a broader market pullback, along with earnings news from small- and micro-cap companies and presentations at multiple conferences.

ACRX

1 minute read

TFF Pharma To Begin Human Trial For Inhaled COVID-19 Therapy In Canada

By Vandana Singh

Today, 1:39 PM

TFF Pharmaceuticals Inc (NASDAQ:TFFP) has received approval from Health Canada to begin a Phase 1 trial of a dry powder formulation…

TFFP

3 minute read

TFF Pharma Reports Received Approval From Health Canada To Enter Human Clinical Trials For Inhaled Formulation Of Niclosamid To Treat COVID-19

By Benzinga Newsdesk

Today, 1:39 PM

First Patient in Phase 1 Trial to be Dosed in November with Enrollment Completion Anticipated by Early Q1 2022 Preclinical Studies of Inhaled Dry Powder Formulation of Niclosamide Showed a Seven-Fold Reduction in Lung

TFFP

1 minute read

12 Health Care Stocks Moving In Tuesday’s Pre-Market Session

By Benzinga Insights

Today, 1:39 PM

ADMP

4 minute read

TFF Pharmaceuticals Shares Spike Higher; Co, Augmenta Bioworks Publish In Vivo Data Co Says Shows Dry Powder Formulation Of COVID-19 Antibody, AUG-3387, Neutralizes SARS-CoV-2 Infection And Reduces Viral Load

By Benzinga Newsdesk

Today, 1:39 PM

TFF Pharmaceuticals, Inc. (NASDAQ:TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology

TFFP

6 minute read

The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology

By Shanthi Rexaline

Today, 1:39 PM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 11)

ABSI

1 minute read

TFF Pharma’s Inhaled Tacrolimus Powder Moves Closer To Phase 2 In Lung Transplantation

By Vandana Singh

Today, 1:39 PM

TFF Pharmaceuticals Inc (NASDAQ:TFFP) has announced topline results from Phase 1 trial for Tacrolimus Inhalation Powder. Data showed a good safety…

TFFP

5 minute read

The Daily Biotech Pulse: Adcom Tryst For Pfizer/BioNTech Booster Shot, AbCellera’s COVID Antibody Treatment Gets Expanded Use, Protagonist Slapped With Clinical Hold

By Shanthi Rexaline

Today, 1:39 PM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 16)

ABCL

6 minute read

The Daily Biotech Pulse: Moderna’s Vaccine Produces Durable Response Against Variants, FDA Approves Jazz’s Sleep Disorder Drug, Dermata IPO

By Shanthi Rexaline

Today, 1:39 PM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 12)

ABVC

1 minute read

TFF Pharmaceuticals Q2 EPS $(0.18) Beats $(0.30) Estimate

By Michael Horton

Today, 1:39 PM

TFF Pharmaceuticals (NASDAQ:TFFP) reported quarterly losses of $(0.18) per share which beat the analyst consensus estimate of $(0.30) by 40 percent. This is a 10 percent increase over losses of $(0.20) per share from the

TFFP